Penn Researchers ID Acetylated Tau as Potential Protein Biomarker for Alzheimer's, Related Disorders
April 08, 2011
Penn Researchers ID Acetylated Tau as Potential Protein Biomarker for Alzheimer's, Related Disorders
Their findings suggest that acetylated tau might be a useful addition to more established AD biomarkers like amyloid-beta, tau, and phosphorylated tau and could help clinicians distinguish between various forms of frontotemporal lobar degeneration.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- AD Working Group Proposes New Alzheimer's Definition to Include Protein Biomarkers
October 15, 2010 / ProteoMonitor - Initial Analysis of ADNI Plasma Proteome Data Suggests Possible Protein Signatures for Alzheimer's
December 10, 2010 / ProteoMonitor - ADNI Researchers and Industry Partners Developing Proteomic Profiles to Track Alzheimer's Disease
June 11, 2010 / ProteoMonitor - Gothenburg Scientists ID Tyr10-Glycosylated A-beta as Potential Alzheimer's Biomarker
July 15, 2011 / ProteoMonitor - Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
June 3, 2011 / ProteoMonitor